4 Stocks That Brokerages Are Recommending To Buy

Investment

oi-Sunil Fernandes

By Sunil Fernandes

Published: Saturday, April 7, 2018, 8:28 [IST]

Markets have recovered a bit from the 10 per cent slump that we seen by the end of March. Here are a few stocks that stock brokerages have on their "buy" list.

TVS Motors

Bonanza is bullish on the stock of TVS Motors and has placed a buy call on the stock.

"With 4th largest 2-wheeler manufacturer, good response to new products in domestic market, continuously launch of new products in domestic market, gaining market share in both the motorcycles and scooter segments, investment in electric vehicle technology and tie up with BMW, we value TVS Motor at 54.60x FY19E EPS of Rs.14.30 to arrive at target price of Rs.771, an upside of 22%," the brokerage firm has noted in its latest report.

The stock of TVS Motors closed at Rs 645 on the NSE. Check stock quote of TVS Motors here

Yes Bank

Brokerage firm Sharekhan is bullish on the stock of Yes Bank and has placed a buy call on the same with a price target of Rs 360.

"The stock of Yes Bank is currently trading at 2.4 times its FY2019E book value, which we believe is reasonable. Notwithstanding the strong overall performance and positive outlook, we believe that near term niggle of higher provisions can be an overhang on the stock performance. We maintain our rating to Buy, with a revised price target (PT) of Rs 360," the brokerage firm has stated. Check stock quote of Yes Bank here

RBL Bank

Axis Direct is bullish on the stock of RBL Bank and has placed a buy call on the stock.

"We expect RBL to scale up materially without any significant teething issues while achieving best in class performance across major parameters. RBL is transitioning from being a wholesale-focused regional player to an agile technology-leader with a diversified portfolio, focus on strategic niche customer segments, and pan-India aspirations.

RBL will command a premium to peers given (1) loan growth 3-4x of industry for foreseeable future, (2) ample scope of improving its low cost deposits and fee income, (3) negligible legacy issues, and (4) value accretion from significant rise in retail assets (tie-up with Bajaj Finance/new gen/e-comm players). We value RBL at 3.4x FY20E P/ABV to arrive at TP of Rs 650. At CMP of Rs 477, RBL trades at 2.5x FY20E P/ABV," the research firm has noted.

Check stock quote of RBL here

Ajanta Pharma

Arihant is bullish on the stock of Ajanta Pharma and has placed a "buy"

"We believe that AJP's long-term fundamentals continue to remain healthy driven by strong traction in the US business (post US FDA clearance to its Dahej unit) and above industry growth in domestic business. Its Sales, EBITDA and PAT witnessed 24%, 37% and 44% CAGR, respectively through FY12-17 owing to strong growth in domestic formulation business and healthy growth in exports (21% CAGR). We have a Target of Rs 1500, valuing the stock at 25x FY19E EPS of Rs 60," the brokerage firm has said in its report.

Disclaimer

This article is strictly for informational purposes only. It is not a solicitation to buy, sell in securities or other financial instruments. Greynium Information Technologies Pvt Ltd, its subsidiaries, associates and the author of this article do not accept culpability for losses and/or damages arising based on information in this article.